AwardTape · Defense awards · Medical · Diagnostics and lab supplies · N6264520P0020
N6264520P0020: -$1.9M purchase order to Biofire Diagnostics LLC
Biofire Diagnostics LLC holds a purchase order from Defense Health Agency with -$1.9M obligated since Oct 2023 and $3.1M obligated over its life, against a ceiling of $3.1M. Latest action Jul 14, 2025.
Molecular assay-analyzer
| PIID | N6264520P0020 |
|---|---|
| Type | purchase order |
| Company | Biofire Diagnostics LLC |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 334516 ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING |
| Obligated since Oct 2023 | -$1.9M |
| Total obligated (lifetime) | $3.1M |
| Ceiling (base and all options) | $3.1M |
| Base date | Apr 16, 2020 |
| Latest action | Jul 14, 2025 |
| End date | Apr 15, 2025 |
| Actions since Oct 2023 | 6 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | UT |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial